\n Brenda Dooley, of AXIS Consulting. Picture: Bryan Meade\n <\/p>\n
Axis Reimbursement, a Dublin-based healthcare consultancy, expects revenue to grow to \u20ac5 million this year.<\/p>\n
The business, which also has offices in Galway and Manchester, was founded by Brenda Dooley in 2011. It has 20 permanent staff, plus a team of 10 contractors, and generated \u20ac3.3 million in revenue last year.<\/p>\n
\u201cWe help patients get access to new innovative medicines by supporting pharmaceutical and biopharmaceutical companies in demonstrating value for money. That\u2019s a state requirement before they get reimbursed,\u201d Dooley told the Business Post.<\/p>\n
\u201cThis enables them to get the medicines onto state reimbursement schemes. Whether that\u2019s in Ireland through the HSE or the NHS in the UK, we get the medicines formally reimbursed by creating value for money evidence.\u201d<\/p>\n
Company DetailsFounded by: Brenda Dooley in 2011Staff: 20Revenue: \u20ac3.3 million in 2025 <\/p>\n
This involves demonstrating clinical effectiveness and cost-effectiveness to justify a drug’s eligibility for reimbursement schemes.<\/p>\n
Dooley has spent her entire working life in the health sector, first as a nurse before moving into the pharmaceutical industry. Across that experience, she developed the idea for Axis Reimbursement.<\/p>\n
\u201cI noticed that market access was becoming a particular aspect of decision-making in Ireland and was becoming more formalised. It was similar to what had happened in the UK a decade prior,\u201d she said.<\/p>\n
\u201cHaving done the job working in Pfizer as head of market access, I decided this was an opportunity to set up my own consultancy. The real problem was that there weren\u2019t many providers of in-country expertise that would inform those submissions.\u201d<\/p>\n
Now 15 years on, the business has grown considerably since Dooley started as a one-woman operation.<\/p>\n
\u201cIt has evolved a lot. In the early days, I was a sole trader and then it started to grow. It was still a small team up until 2018, then we started to really build. In many ways, Covid was good for us as we pivoted and could work hybrid and online. That allowed us to reach more international audiences,\u201d she said.<\/p>\n
\u201cWe\u2019ve expanded since. Traditionally we were an Irish-focused company; we built ourselves into the leader in Ireland. Three years ago we expanded into the UK, where we have 6 per cent of the market share now.\u201d<\/p>\n